AI English summary of an SEC filing — figures as filed
Cardinal Health CAHCardinal Health said Steven K. Barg and Sujatha Chandrasekaran, both board members since 2022, informed the company on September 6, 2024 and September 8, respectively, that they will not stand for re-election when their terms expire at the 2024 annual shareholders meeting.
Key points
AI summaryCardinal Health said Steven K. Barg and Sujatha Chandrasekaran, both board members since 2022, informed the company on September 6, 2024 and September 8, respectively, that they will not stand for re-election when their terms expire at the 2024 annual shareholders meeting.
The company said Barg and Chandrasekaran will continue to serve as directors until the 2024 annual shareholders meeting. The two said their decisions are not the result of any disagreement with the company on any matter relating to its operations, policies or practices.
The company said the two were originally appointed to the board under a cooperation agreement entered into on September 5, 2022 between the company and Elliott Associates, L.P. and Elliott International, L.P. Barg said he served on the board's Business Review Committee as Elliott's investor designee.
The company said the Business Review Committee sunsetted on July 15, 2024. Barg currently serves on the Governance and Sustainability Committee, and Chandrasekaran serves on the Audit and Risk Oversight Committees.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Two directors to not seek re-election
Cardinal Health said Steven K. Barg and Sujatha Chandrasekaran, both board members since 2022, informed the company on September 6, 2024 and September 8, respectively, that they will not stand for re-election when their terms expire at the 2024 annual shareholders meeting.
Source · Based on the filing body and exhibits
Directors to remain on board until annual meeting
The company said Barg and Chandrasekaran will continue to serve as directors until the 2024 annual shareholders meeting. The two said their decisions are not the result of any disagreement with the company on any matter relating to its operations, policies or practices.
Source · Based on the filing body and exhibits
Appointment under Elliott cooperation agreement
The company said the two were originally appointed to the board under a cooperation agreement entered into on September 5, 2022 between the company and Elliott Associates, L.P. and Elliott International, L.P. Barg said he served on the board's Business Review Committee as Elliott's investor designee.
Source · Based on the filing body and exhibits
Committee roles and Business Review Committee sunset
The company said the Business Review Committee sunsetted on July 15, 2024. Barg currently serves on the Governance and Sustainability Committee, and Chandrasekaran serves on the Audit and Risk Oversight Committees.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…